AVI BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results and Corporate Update Conference Call (Marketwire)

9 March 2010, 5:12 am

BOTHELL, WA--(Marketwire - March 9, 2010) - AVI BioPharma, Inc. ( NASDAQ : AVII ), a developer of RNA-based drugs, will report fourth quarter and full year 2009 financial results before the NASDAQ Global Market opens on Tuesday, March 16, 2010. Subsequently, at 8:30 a.m. Eastern time (5:30 a.m. Pacific time), Dr. Leslie Hudson, AVI's President and Chief Executive Officer, and J. David Boyle II ...... Read More »

More Topics from "News"

• Real estate notebook (Everett Herald)
• Medical device entrepreneur Joe Eichinger dies (Seattle Times)
• Washington state Senate OKs $890 million in tax hikes (Everett Herald)
• OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2009 and Provides Outlook for 2010 (CNW Group via Yahoo! Finance)
• OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2009 and Provides Outlook for 2010 (PR Newswire via Yahoo! Finance)
• Man arrested after crash on I-5 bridge (The Columbian)
• MDRNA, Inc. Announces Upcoming Investor Conference Presentations (Marketwire)
• MDRNA, Inc. Announces Upcoming Investor Conference Presentations (Marketwire via Yahoo! Finance)
• Letters to the editor (Seattle Times)